Orchestra BioMed Holdings, Inc. (OBIO) Operating margin 2022–2025
Orchestra BioMed Holdings, Inc. (OBIO) operating margin by fiscal year — reported operating income divided by reported revenue.
-154.7%FY2025 · since FY2022: -924.3% → -154.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -154.7% | +2282.8 pp |
| FY2024 | -2437.5% | -571.3 pp |
| FY2023 | -1866.2% | -941.8 pp |
| FY2022 | -924.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More OBIO financial trends
OBIO RevenueOBIO Net incomeOBIO Net marginOBIO Gross profitOBIO Gross marginOBIO Operating incomeOBIO Operating cash flowOBIO Free cash flowOBIO Capital expendituresOBIO Return on equityOBIO Stock buybacksOBIO Dividends paidOBIO Total assetsOBIO Total liabilitiesOBIO Shareholders’ equityOBIO overview →